8.89
Avantor Inc stock is traded at $8.89, with a volume of 11.83M.
It is down -1.55% in the last 24 hours and down -24.66% over the past month.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
See More
Previous Close:
$9.03
Open:
$8.92
24h Volume:
11.83M
Relative Volume:
1.07
Market Cap:
$6.06B
Revenue:
$6.82B
Net Income/Loss:
$309.60M
P/E Ratio:
19.76
EPS:
0.45
Net Cash Flow:
$747.20M
1W Performance:
-3.37%
1M Performance:
-24.66%
6M Performance:
-33.01%
1Y Performance:
-48.61%
Avantor Inc Stock (AVTR) Company Profile
Name
Avantor Inc
Sector
Industry
Phone
(610) 386-1700
Address
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AVTR
Avantor Inc
|
8.89 | 6.16B | 6.82B | 309.60M | 747.20M | 0.45 |
|
ISRG
Intuitive Surgical Inc
|
492.10 | 179.00B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
184.34 | 52.74B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
49.64 | 41.44B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ALC
Alcon Inc
|
82.85 | 40.59B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
260.79 | 37.75B | 5.40B | 1.49B | 1.78B | 10.12 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-17-25 | Downgrade | Jefferies | Hold → Underperform |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-04-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-01-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-29-25 | Downgrade | Goldman | Buy → Neutral |
| Apr-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Apr-28-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-17-25 | Downgrade | UBS | Buy → Neutral |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-11-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-31-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-21-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Oct-05-22 | Upgrade | Citigroup | Neutral → Buy |
| Sep-14-22 | Downgrade | Cowen | Outperform → Market Perform |
| Sep-09-22 | Downgrade | Cleveland Research | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-30-21 | Resumed | Raymond James | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Aug-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-04-21 | Initiated | Goldman | Buy |
| Apr-29-21 | Upgrade | Stifel | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Aug-02-19 | Initiated | Cleveland Research | Neutral |
| Jun-14-19 | Initiated | Janney | Buy |
| Jun-12-19 | Initiated | Raymond James | Outperform |
| Jun-11-19 | Initiated | Goldman | Buy |
| Jun-11-19 | Initiated | Guggenheim | Buy |
| Jun-11-19 | Initiated | JP Morgan | Overweight |
| Jun-11-19 | Initiated | Jefferies | Buy |
| Jun-11-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| Jun-11-19 | Initiated | RBC Capital Mkts | Outperform |
| Jun-11-19 | Initiated | Robert W. Baird | Outperform |
| Jun-11-19 | Initiated | SunTrust | Buy |
| Jun-11-19 | Initiated | UBS | Buy |
| Jun-11-19 | Initiated | William Blair | Outperform |
View All
Avantor Inc Stock (AVTR) Latest News
Avantor’s Two-Segment Reset—A Strategic Masterstroke or Execution Risk in Disguise? - Smartkarma
Avantor director Lucier buys $458,000 in company stock By Investing.com - Investing.com Australia
Avantor stock hits 52-week low at $8.89 By Investing.com - Investing.com Australia
Avantor stock hits 52-week low at $8.89 - Investing.com
Avantor Stock Fell 50% Last Year and Sits Near a 52-Week Low. Could it Recover in 2026? - TIKR.com
Ontario Teachers Pension Plan Board Invests $3.68 Million in Avantor, Inc. $AVTR - MarketBeat
Avantor, Inc. $AVTR Shares Sold by Readystate Asset Management LP - MarketBeat
Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, David Einhorn, Appaloosa Management, Brevan Howard Asset Management, Maverick Capital, Viking Global, DraftKings Inc (DKNG), Avantor Inc (AVTR), and More - Insider Monkey
Avantor Reports Q4 Profit, Full-Year Loss for 2025 - MyChesCo
Avantor, Inc. $AVTR Stock Position Increased by Envestnet Asset Management Inc. - MarketBeat
Bear of the Day: Avantor (AVTR) - Finviz
Archrock and Avantor have been highlighted as Zacks Bull and Bear of the Day - Bitget
The 5 Most Interesting Analyst Questions From Avantor's Q4 Earnings Call - Finviz
The 5 Most Interesting Analyst Questions From Avantor’s Q4 Earnings Call - TradingView
Avantor, Inc. $AVTR Shares Sold by Rhumbline Advisers - MarketBeat
Avantor shares drop more than 5% as turnaround efforts fail to excite investors - MSN
Short Interest in Avantor, Inc. (NYSE:AVTR) Expands By 25.3% - MarketBeat
Invesco Ltd. Purchases 119,508 Shares of Avantor, Inc. $AVTR - MarketBeat
Analysts Have Conflicting Sentiments on These Healthcare Companies: Avantor (AVTR) and Moderna (MRNA) - The Globe and Mail
Assessing Avantor (AVTR) Valuation After Prolonged Share Price Weakness - Yahoo Finance
Avantor (AVTR) PT lowered to $11 by BofA following soft FY 2026 guidance - MSN
Avantor (AVTR) PT Lowered to $11 by BofA Following Soft FY 2026 Guidance - Finviz
Has Avantor (AVTR) Fallen Too Far After Multi Year Share Price Slide - Yahoo Finance
What Analysts Are Saying About Avantor Stock - Benzinga
Avantor (NYSE:AVTR) Given New $14.00 Price Target at Wells Fargo & Company - MarketBeat
Applied Materials To Rally Around 37%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
The Market Doesn't Like What It Sees From Avantor, Inc.'s (NYSE:AVTR) Revenues Yet As Shares Tumble 27% - simplywall.st
Avantor (NYSE:AVTR) Director Acquires $940,000.00 in Stock - MarketBeat
The Truth About Avantor Inc: Why Wall Street Won’t Shut Up About AVTR - AD HOC NEWS
UBS Cuts Avantor Price Target to $10.50 From $13, Maintains Neutral Rating - marketscreener.com
AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline - TradingView
Deutsche Bank Cuts Price Target on Avantor to $9 From $12.50, Keeps Hold Rating - marketscreener.com
Avantor, Inc. (NYSE:AVTR) Q4 2025 Earnings Call Transcript - Insider Monkey
Avantor Inc stock hits 52-week low at $8.90 By Investing.com - Investing.com South Africa
Avantor Q4 2025 slides: Revenue declines as company launches revival plan By Investing.com - Investing.com South Africa
AVTR Q4 Deep Dive: Strategic Overhaul and Market Transition Shape 2026 Outlook - Finviz
Avantor reports Q4 sales decline as “Revival” turnaround begins - AlphaStreet News
(AVTR) Risk Channels and Responsive Allocation - Stock Traders Daily
Avantor (AVTR) Q3 Loss Of US$711.8 Million Tests Bullish Earnings Narratives - simplywall.st
Avantor Inc (AVTR) Stock Price, Quote, News & History - Benzinga
Avantor Inc stock hits 52-week low at $8.90 - Investing.com Nigeria
Avantor Earnings Call: Strategy Advances, Profits Squeezed - TipRanks
Avantor Q4 2025 slides: Revenue declines as company launches revival plan - Investing.com Nigeria
Avantor® Reports Fourth Quarter and Full Year 2025 Results - The Malaysian Reserve
Avantor stock price target lowered to $11 by BofA on weak outlook - Investing.com Australia
Research Alert: CFRA Maintains Hold View On Shares Of Avantor, Inc. - 富途牛牛
Avantor Inc (AVTR) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
Is Avantor Inc. still a buy after recent gainsWeekly Trade Summary & Reliable Price Action Trade Plans - mfd.ru
Avantor (NYSE:AVTR) Issues FY 2026 Earnings Guidance - MarketBeat
Avantor Inc Stock (AVTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):